Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hemo OrganicBOM:524590 29 ROE % is -223.33% as of Jun. 2026. GuruFocus rates BOM:524590 with a GF Score™ of 29/100. The stock has 8 warning signs investors should review. Among 551 Conglomerates companies, Hemo Organic ranks worse than 181488.02% on this metric.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Hemo Organic's annualized net income for the quarter that ended in Jun. 2026 was ₹-2.97 Mil. Hemo Organic's average Total Stockholders Equity over the quarter that ended in Jun. 2026 was ₹1.33 Mil. Therefore, Hemo Organic's annualized ROE % for the quarter that ended in Jun. 2026 was -223.33%.
The historical rank and industry rank for Hemo Organic's ROE % or its related term are showing as below:
BOM:524590's ROE % is not ranked *
in the Conglomerates industry.
Industry Median: 6.34 * Ranked among companies with meaningful ROE % only.
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Jun. 2026) net income data. The Revenue data used here is four times the quarterly (Jun. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Hemo Organic ROE % Related Terms
Hemo Organic ROE % Historical Data
* Premium members only.
The historical data trend for Hemo Organic's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Conglomerates subindustry, Hemo Organic's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hemo Organic ROE % vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Hemo Organic's ROE % distribution charts can be found below:
* The bar in red indicates where Hemo Organic's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Jun. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Hemo Organic (BOM:524590) has a ROE % of -223.33% as of Jun. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Hemo Organic and its competitors. According to the industry distribution chart, Hemo Organic ranks #999999 out of 551 companies in the Conglomerates industry.
Is Hemo Organic's ROE % too high?
Hemo Organic's current ROE % is -223.33%. Based on the distribution chart, Hemo Organic ranks #999999 out of 551 companies in the Conglomerates industry, which is in the bottom quartile relative to peers. Overall, Hemo Organic has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Hemo Organic's ROE % compare to MMM and HON?
According to the Conglomerates industry distribution chart, Hemo Organic ranks #999999 out of 551 companies for ROE %. This places Hemo Organic in the lower half of its industry. The industry median ROE % is 6.34. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Conglomerates company?
The median ROE % among Conglomerates companies is 6.34, based on 551 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Hemo Organic and its competitors. For the Conglomerates industry, the median ROE % is 6.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hemo Organic's current ROE % is -223.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hemo Organic stock overvalued right now?
Hemo Organic (BOM:524590) has a current ROE % of -223.33%. The current ROE % is -223.33%. Hemo Organic's overall GF Score™ is 29/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Hemo Organic (BOM:524590), the current ROE % is -223.33% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hemo Organic Ltd is mainly focused on trading and distribution, particularly in rice and textiles. The company buys, sells, imports, exports, and distributes agricultural commodities such as wheat, rice, maize, vegetables, and fruits at both retail and wholesale levels, maintaining high standards across domestic and international markets. Its portfolio includes wheat, rice, maize, vegetables like capsicum, tomato, green chili, onion, and potato, as well as fruits including apple, red dragon fruit, sweet lime, and pomegranate.
29GF Score
Get the complete analysis for BOM:524590
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524590 has been successfully added to your 
